Topoisomerase II inhib 
Welcome,         Profile    Billing    Logout  
 47 Companies  56 Products   56 Products   424 Diseases   2079 Trials   102603 News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Products
 02468101214161820
            
                                                                                                      
            
Generic mfg.           
          
            
CSPC Pharma           
          
            
Xoma           
          
            
BMS           
          
            
Imunon           
          
            
Teva           
          
            
AEterna Zentaris           
          
            
AbbVie           
          
            
Allarity Therap           
          
            
Avacta           
          
            
CNS Pharma           
          
            
CellAct Pharma           
          
            
Daiichi Sankyo           
          
            
Denovo           
          
            
Dong Wha           
          
            
GSK           
          
            
Gilead           
          
            
ImmunityBio           
          
            
Innomedica           
          
            
Intezyne           
          
            
Jazz           
          
            
Kyowa Kirin           
          
            
LadRx           
          
            
Menarini           
          
            
Merrimack           
          
            
Molecular Targeting Tech           
          
            
Monopar Therap           
          
            
Mundipharma           
          
            
Neovia Oncology           
          
            
Nippon Kayaku           
          
            
Nippon Shinyaku           
          
            
Noxopharm           
          
            
Orient Europharma           
          
            
Pfizer           
          
            
Pierre Fabre           
          
            
Royalty           
          
            
SRI International           
          
            
Seagen           
          
            
Servier           
          
            
Shasqi           
          
            
Sopherion           
          
            
Sumitomo Pharma           
          
            
Taivex Therapeutics Corporation           
          
            
Teclison           
          
            
Viracta Therap           
          
            
WPD Pharma